BioVie (BIVI)
(Delayed Data from NSDQ)
$0.48 USD
0.00 (-0.84%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $0.49 +0.01 (1.07%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
Cash flow Statements
Fiscal Year End for BioVie Inc falls in the month of June.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -50.26 | -26.08 | -130.25 | -16.68 | -2.44 |
Depreciation/Amortization & Depletion | 0.44 | 0.34 | 0.23 | 0.23 | 0.23 |
Net Change from Assets/Liabilities | -0.27 | 2.75 | 0.02 | 0.77 | -0.45 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 9.84 | 4.01 | 119.55 | 14.05 | 0.17 |
Net Cash From Operating Activities | -40.25 | -18.99 | -10.45 | -1.63 | -2.50 |
Property & Equipment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | -14.30 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -14.30 | 0.00 | 0.00 | 0.00 | 0.00 |
Uses of Funds
6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 55.37 | 18.51 | 16.31 | 0.00 | 3.04 |
Issuance (Repayment) of Debt | 0.00 | 14.61 | -1.39 | 1.33 | -0.24 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 55.37 | 33.12 | 14.93 | 1.33 | 2.80 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 0.82 | 14.13 | 4.47 | -0.30 | 0.29 |
Cash at Beginning of Period | 18.64 | 4.51 | 0.04 | 0.34 | 0.05 |
Cash at End of Period | 19.46 | 18.64 | 4.51 | 0.04 | 0.34 |
Diluted Net EPS | -1.55 | -1.06 | -14.82 | -6.85 | NA |
Fiscal Year End for BioVie Inc falls in the month of June.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -19.11 | -10.71 | -50.26 | -41.14 |
Depreciation/Amortization & Depletion | NA | 0.18 | 0.10 | 0.44 | 0.30 |
Net Change from Assets/Liabilities | NA | -0.17 | -2.27 | -0.27 | 1.10 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 1.01 | 0.71 | 9.84 | 10.78 |
Net Cash From Operating Activities | NA | -18.09 | -12.18 | -40.25 | -28.97 |
Property & Equipment | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 14.53 | 14.53 | -14.30 | -12.50 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | 14.53 | 14.53 | -14.30 | -12.50 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 9.33 | 1.91 | 55.37 | 54.10 |
Issuance (Repayment) of Debt | NA | -5.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | -2.50 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | 4.33 | -0.59 | 55.37 | 54.10 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | 0.77 | 1.75 | 0.82 | 12.63 |
Cash at Beginning of Period | NA | 19.46 | 19.46 | 18.64 | 18.64 |
Cash at End of Period | NA | 20.23 | 21.21 | 19.46 | 31.28 |
Diluted Net EPS | NA | -0.22 | -0.29 | -0.24 | -0.43 |